Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen Extended Release vs Rofecoxib in Knee Osteoarthritis
NCT00568295Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 1999
- Primary completion
- Oct 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of acetaminophen in osteoarthritis (OA) (3 arms), sponsored by Johnson & Johnson. Primary endpoint: Western Ontario and McMaster Universities (WOMAC) pain subscale score at 4 weeks. Started Oct 1999; status: completed.
02
Drugs
acetaminophen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00568295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568295.